| Synonyms: | |
| Status: | Approved (2018) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | B06AC05 |
| UNII: | 2372V1TKXK |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Plasma kallikrein inhibitor | PubMed |
| Primary Target | |
|---|---|
| kallikrein B1 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Angioedemas, Hereditary | 4 | D054179 | ClinicalTrials |
| Angioedema | 3 | D000799 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Wounds and Injuries | 1 | D014947 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1426055-14-2 |
| ChEMBL | CHEMBL3545189 |
| FDA SRS | 2372V1TKXK |
| Guide to Pharmacology | 9094 |
CONTENTS